These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26337114)

  • 1. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
    Wales M; Cartier E
    Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patentability of Stem Cells in the United States.
    Fendrick SE; Zuhn DL
    Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
    Pereira DJ; Kunin SG
    Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

  • 7. The Supreme Court's revolution in patent eligibility law: alternative protections for biotechnology.
    Taylor DO
    Nat Biotechnol; 2019 Mar; 37(3):227-230. PubMed ID: 30833760
    [No Abstract]   [Full Text] [Related]  

  • 8. Harvard v. Canada: the myc mouse that still squeaks in the maze of biopatent law.
    Deftos LJ
    Acad Med; 2001 Jul; 76(7):684-92. PubMed ID: 11448821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of US patents and the patent system.
    Elliott G
    AAPS J; 2007 Aug; 9(3):E317-24. PubMed ID: 17915834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual property. Biotech feels a chill from changing U.S. patent rules.
    Servick K
    Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626
    [No Abstract]   [Full Text] [Related]  

  • 11. US Supreme Court applies strict limits to patents.
    Robertson D
    Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
    [No Abstract]   [Full Text] [Related]  

  • 12. Patents. U.S. Supreme Court delves into what is and isn't patentable.
    Marshall E
    Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
    [No Abstract]   [Full Text] [Related]  

  • 13. Supreme Court boosts licensees in biotech patent battles.
    Waltz E
    Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
    [No Abstract]   [Full Text] [Related]  

  • 14. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation.
    Binnie I; Park-Thompson V
    Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supreme Court to Myriad Genetics: Synthetic DNA is Patentable but Isolated Genes Are Not.
    Weinmeyer R; Klusty T
    AMA J Ethics; 2015 Sep; 17(9):849-53. PubMed ID: 26390207
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology patents under fire.
    Royzman I
    Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
    [No Abstract]   [Full Text] [Related]  

  • 19. Inventions in biotechnology and the assessment of obviousness.
    Finney K
    Australas Biotechnol; 1994; 4(5):280-3. PubMed ID: 7765674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The end of DNA patents in the United States?
    Webber P
    Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.